Coromandel International Limited Earnings Summary — Q4 FY2026
Coromandel International Reports Q4 Earnings Amid Margin Contraction and Profit Dip
Key Takeaways
- Net profit witnessed a substantial 80% year-on-year decline to ₹115 crore in Q4 FY2026.
- Despite the profit dip, quarterly revenue grew 20% compared to the same period last year.
- Tax expense spiked to 50% in the current quarter, significantly impacting the bottom line.
- The company is undergoing a heavy Capex cycle, with Fixed Assets and CWIP increasing to ₹6,790 crore.
- Borrowings have nearly doubled in the last year to ₹1,506 crore to fund expansion and working capital.
- Other income turned negative this quarter (-₹6 Cr) versus a high base of ₹473 Cr in the previous year's Q4.
- Depreciation costs have risen sharply to ₹165 crore as new capacities come online.
Management Guidance
Management remains focused on de-risking the business from fertilizer subsidies by expanding the Crop Protection and Biologicals segments toward a 25% profit contribution target.
Sentiment Shift
Deteriorating
A sharp decline in net profit and a spike in the tax rate and borrowing costs outweigh the moderate year-on-year revenue growth.
Outlook
The company is transitioning into a diversified agri-solutions provider with a focus on biologicals and exports to mitigate domestic monsoon risk; however, short-term earnings remain pressured by higher interest and depreciation.
From the Annual Report (Key Quotes)
“Coromandel is India’s second-largest phosphatic fertilizer player and a dominant force in high-margin complex fertilizers.”
“Strategic focus on the ‘Biologicals’ business and global exports provides a structural growth tailwind.”
“Management is highly regarded for its corporate governance standards and strategic long-term vision.”
Earnings Call Transcript — Q4 FY2026
Transcript is fetched on demand to save crawl credits. Click below to load the latest earnings call transcript for this quarter.
This summary is AI-generated from Coromandel International Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.